Farias Galileu F A, de Moura Diogo T H, de Moura Eduardo T H, de Rezende Daniel T, Hathorn Kelly E, Nasi Ary, Queiroz Natália S F, de Moura Eduardo G H
Gastrointestinal Endoscopy Unit, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
Division of Gastroenterology, Hepatology and Endoscopy, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States.
Endosc Int Open. 2020 Apr;8(4):E506-E512. doi: 10.1055/a-1035-9288. Epub 2020 Mar 23.
Achalasia can be classified as either primary (idiopathic) achalasia or secondary achalasia, which is a consequence of another systemic disease. Peroral endoscopic myotomy (POEM) is an effective and safe treatment for achalasia. We evaluated the efficacy and safety of POEM in patients with Chagasic achalasia compared to idiopathic achalasia. We evaluated POEM procedures performed at a single institution from November 2016 to January 2018. Demographic data, Eckardt score, lower esophageal sphincter (LES) pressure, body mass index, post-operative erosive esophagitis, adverse events, length of hospital stay, and procedure-related parameters were analyzed. Fifty-one patients underwent POEM as a treatment for achalasia in this period (20 patients with Chagasic and 31 with Idiopathic etiology). The overall clinical success rate was 92.1 %, with no statistical difference between groups (90 % in the Chagasic group vs. 93.5 % in the Idiopathic group, = 0.640). Both groups had significant reduction in Eckardt score and in LES pressure, and increase in bodey mass index (BMI) at 1-year follow-up. There was no statistical difference between groups regarding Eckardt score ( = 0.439), LES pressure (p = 0.507), BMI ( = 0.254), post erosive esophagitis (35 % vs. 38.7 %, = 0.789), adverse events (30 % vs. 12 %, = 0.163,) length of hospital stay (3.75 days vs. 3.58 days, = 0.622), and operative time (101.3 min vs. 99.1 min, = 0.840). POEM is an effective and safe treatment for patients with achalasia. There is no difference in POEM outcomes for those patients with Chagasic or Idiopathic achalasia.
贲门失弛缓症可分为原发性(特发性)贲门失弛缓症或继发性贲门失弛缓症,后者是另一种全身性疾病的结果。经口内镜下肌切开术(POEM)是治疗贲门失弛缓症的一种有效且安全的方法。我们评估了POEM治疗南美锥虫病性贲门失弛缓症患者与特发性贲门失弛缓症患者相比的疗效和安全性。我们评估了2016年11月至2018年1月在单一机构进行的POEM手术。分析了人口统计学数据、埃卡德特评分、食管下括约肌(LES)压力、体重指数、术后糜烂性食管炎、不良事件、住院时间和手术相关参数。在此期间,51例患者接受了POEM治疗贲门失弛缓症(20例为南美锥虫病性,31例为特发性病因)。总体临床成功率为92.1%,两组之间无统计学差异(南美锥虫病组为90%,特发性组为93.5%,P = 0.640)。两组在1年随访时埃卡德特评分和LES压力均显著降低,体重指数(BMI)增加。两组在埃卡德特评分(P = 0.439)、LES压力(P = 0.507)、BMI(P = 0.254)、术后糜烂性食管炎(35%对38.7%,P = 0.789)、不良事件(30%对12%,P = 0.163)、住院时间(3.75天对3.58天,P = 0.622)和手术时间(101.3分钟对99.1分钟,P = 0.840)方面无统计学差异。POEM是治疗贲门失弛缓症患者的一种有效且安全的方法。对于患有南美锥虫病性或特发性贲门失弛缓症的患者,POEM的治疗结果没有差异。